Literature DB >> 3802700

Effect of food on the absorption of enteric-coated aspirin: correlation with gastric residence time.

P Mojaverian, M L Rocci, D P Conner, W B Abrams, P H Vlasses.   

Abstract

The Heidelberg capsule is an indigestible indicator of gastrointestinal pH, which was used to evaluate the relationship between gastric residence time (GRT) and variability in aspirin absorption from enteric-coated tablets. In a crossover study, eight healthy subjects (four men and four women) received an enteric-coated aspirin (648 mg) together with a Heidelberg capsule while fasting or with food (breakfast, followed 4 hours later by lunch). Salicylic acid and salicyluric acid concentrations in plasma and urine were measured by HPLC. The mean (+/- SD) GRT was significantly delayed by food (0.8 +/- 0.5 vs. 5.9 +/- 3.3 hours; P less than 0.005). The mean (+/- SD) lag time (TL) and time to peak concentration (expressed as salicylic acid equivalents) were markedly prolonged after the fed regimen (2.7 +/- 0.8 vs. 8.9 +/- 3.7 hours [P less than 0.005] and 8.3 +/- 2.9 vs. 13.8 +/- 4.5 hours [P less than 0.025]). For the combined data from the fasting and fed evaluations, an excellent correlation existed between TL and GRT of the capsule (TL = 1.0 GRT + 1.95; n = 16; r = 0.94; P less than 0.0001). Women demonstrated greater delays in GRT and TL than did men. The delay in aspirin absorption from an enteric-coated tablet is directly related to its GRT, which is gender related and greatly affected by food.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3802700     DOI: 10.1038/clpt.1987.3

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  23 in total

1.  Impact of regional intestinal pH modulation on absorption of peptide drugs: oral absorption studies of salmon calcitonin in beagle dogs.

Authors:  Y H Lee; B A Perry; S Labruno; H S Lee; W Stern; L M Falzone; P J Sinko
Journal:  Pharm Res       Date:  1999-08       Impact factor: 4.200

2.  Biopharmaceutical characterisation of a low-dose (75 mg) controlled-release aspirin formulation.

Authors:  W N Charman; S A Charman; D C Monkhouse; S E Frisbee; E A Lockhart; S Weisman; G A Fitzgerald
Journal:  Br J Clin Pharmacol       Date:  1993-11       Impact factor: 4.335

3.  Correlation of in vitro release rate and in vivo absorption characteristics of four chlorpheniramine maleate extended-release formulations.

Authors:  P Mojaverian; E Radwanski; C C Lin; P Cho; W A Vadino; J M Rosen
Journal:  Pharm Res       Date:  1992-04       Impact factor: 4.200

Review 4.  What is "fasting" drug administration? On the role of gastric motility in drug absorption.

Authors:  I Walter-Sack
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 5.  Novel drug delivery systems. An overview of their impact on clinical pharmacokinetic studies.

Authors:  P S Banerjee; J R Robinson
Journal:  Clin Pharmacokinet       Date:  1991-01       Impact factor: 6.447

6.  Mechanisms and variations in the food effect on propranolol bioavailability.

Authors:  H Liedholm; E Wåhlin-Boll; A Melander
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

7.  Gastric emptying of indigestible tablets in relation to composition and time of ingestion of meals studied by metal detector.

Authors:  K Ewe; A G Press; S Bollen; I Schuhn
Journal:  Dig Dis Sci       Date:  1991-02       Impact factor: 3.199

8.  Gender-related differences in gastric emptying rate of solid meals.

Authors:  G Hermansson; R Sivertsson
Journal:  Dig Dis Sci       Date:  1996-10       Impact factor: 3.199

9.  Regional differences in intestinal spreading and pH recovery and the impact on salmon calcitonin absorption in dogs.

Authors:  Y H Lee; B A Perry; J P Sutyak; W Stern; P J Sinko
Journal:  Pharm Res       Date:  2000-03       Impact factor: 4.200

10.  Application of dual radiotelemetric technique in studying drug-drug interaction between diclofenac sodium and ranitidine HCl in volunteers.

Authors:  C Alioth; R A Blum; D T D'Andrea; G M Kochak; L Teng; B A Ziehmer; J J Schentag; K K Chan
Journal:  Pharm Res       Date:  1993-11       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.